Latest It Compliance News

Kina Securities Limited has launched its inaugural unsecured subordinated bond issue worth PGK 235 million, offering a fixed 7.55% coupon over 10 years, marking a significant step in Papua New Guinea's capital markets.

Classic Minerals has engaged AFDC to conduct a strategic review and is raising A$3 million to advance exploration at its Forrestania gold project and support its ASX relisting efforts.

Variscan Mines has obtained Supreme Court approval to rectify a delayed cleansing notice related to a major share issue, paving the way for trading to resume. The company has also committed to strengthening its compliance procedures following the oversight.

H&G High Conviction Limited has been suspended from ASX trading due to failing to meet operational requirements, raising questions about its future as a listed entity.

Lithium Energy Limited has revealed a detailed two-year, $36 million plan to advance its battery minerals projects, supported by a robust $68 million cash position as it prepares for ASX relisting.

Latitude Group Holdings is considering launching a new Capital Notes 2 offer, potentially allowing existing CN1 holders to reinvest. The offer will require applications through appointed Syndicate Brokers under updated regulatory rules.

Racura Oncology has secured governance approval to launch its Phase 1 HARNESS-1 trial, testing RC220 alongside osimertinib in EGFR-mutated non-small cell lung cancer patients. This milestone sets the stage for a potentially pivotal new approach to overcoming resistance in lung cancer treatment.

ABx Group has announced a breakthrough with its second mixed rare earth carbonate sample from Tasmania’s Deep Leads deposit, boasting higher heavy rare earth content and fewer impurities. This advancement enhances project flexibility and strengthens ABx’s position in the competitive rare earths market.

NeuRizer Limited has secured a pivotal partnership with Reliance Industries, enabling it to resolve funding challenges and accelerate its Leigh Creek urea project. This collaboration marks a turning point for the company, allowing it to exit suspension and advance critical regulatory and operational milestones.

ARC Funds Limited has been suspended from ASX trading due to a failure to maintain the minimum number of directors required by law, raising questions about its governance and future compliance.

Findi Limited has extended the closing date of its offer to 19 March 2026 and updated details following a $25 million institutional placement. The company’s share capital structure and financial position have been revised, with key changes including director participation and lead manager incentives.

Immutep Limited’s shares have resumed trading following the release of an interim futility analysis from its pivotal TACTI-004 Phase III trial of eftilagimod alfa.